Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer.

Fenn K, Maurer M, Lee SM, Crew KD, Trivedi MS, Accordino MK, Hershman DL, Kalinsky K.

Clin Breast Cancer. 2019 Aug 29. pii: S1526-8209(19)30663-9. doi: 10.1016/j.clbc.2019.08.004. [Epub ahead of print]

PMID:
31570268
2.

Quality of Care and Outcomes of Patients With Gynecologic Malignancies Treated at Safety-Net Hospitals.

Gamble CR, Huang Y, Tergas AI, Khoury-Collado F, Hou JY, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

JNCI Cancer Spectr. 2019 Jun 7;3(3):pkz039. doi: 10.1093/jncics/pkz039. eCollection 2019 Sep.

3.

Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes.

Schlechtweg K, Chen L, St Clair CM, Tergas AI, Khoury-Collado F, Hou JY, Melamed A, Neugut AI, Hershman DL, Wright JD.

Gynecol Oncol. 2019 Sep 10. pii: S0090-8258(19)31522-7. doi: 10.1016/j.ygyno.2019.09.004. [Epub ahead of print]

PMID:
31519319
4.

Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications.

Unger JM, Nghiem VT, Hershman DL, Vaidya R, LeBlanc M, Blanke CD.

JAMA Netw Open. 2019 Sep 4;2(9):e1910593. doi: 10.1001/jamanetworkopen.2019.10593.

5.

Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy.

Altoe ML, Marone A, Kim HK, Kalinsky K, Hershman DL, Hielscher AH, Ha RS.

Biomed Opt Express. 2019 Aug 1;10(8):4305-4315. doi: 10.1364/BOE.10.004305. eCollection 2019 Aug 1.

6.

Clinical decision support for therapeutic decision-making in cancer: A systematic review.

Beauchemin M, Murray MT, Sung L, Hershman DL, Weng C, Schnall R.

Int J Med Inform. 2019 Oct;130:103940. doi: 10.1016/j.ijmedinf.2019.07.019. Epub 2019 Aug 12.

PMID:
31450082
7.

A comparison of nurses' and physicians' perception of cancer treatment burden based on reported adverse events.

Lee SM, Miao J, Wu R, Unger JM, Cheung K, Hershman DL.

Health Qual Life Outcomes. 2019 Aug 22;17(1):146. doi: 10.1186/s12955-019-1210-1.

8.

Trends in Medical Aid in Dying in Oregon and Washington.

Al Rabadi L, LeBlanc M, Bucy T, Ellis LM, Hershman DL, Meyskens FL Jr, Taylor L, Blanke CD.

JAMA Netw Open. 2019 Aug 2;2(8):e198648. doi: 10.1001/jamanetworkopen.2019.8648.

9.

Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation.

Latham AH, Chen L, Hou JY, Tergas AI, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Gynecol Oncol. 2019 Oct;155(1):13-20. doi: 10.1016/j.ygyno.2019.07.021. Epub 2019 Aug 6.

PMID:
31395371
10.

Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims.

Barzi A, Hershman DL, Till C, Barlow WE, Ramsey S, Lenz HJ, Hochster HS, Unger JM.

Arch Osteoporos. 2019 Jul 28;14(1):83. doi: 10.1007/s11657-019-0629-7.

PMID:
31352608
11.

Effect of regionalization of endometrial cancer care on site of care and patient travel.

Knisely A, Huang Y, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2019 Jul 22. pii: S0002-9378(19)30910-X. doi: 10.1016/j.ajog.2019.07.026. [Epub ahead of print]

PMID:
31344350
12.

Use and Misuse of Opioids After Gynecologic Surgical Procedures.

Wright JD, Huang Y, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Neugut AI, Hershman DL.

Obstet Gynecol. 2019 Aug;134(2):250-260. doi: 10.1097/AOG.0000000000003358.

PMID:
31306333
13.

Factors Associated with Multidisciplinary Consultations in Patients with Early Stage Breast Cancer.

Quyyumi FF, Wright JD, Accordino MK, Buono D, Law CW, Hillyer GC, Neugut AI, Hershman DL.

Cancer Invest. 2019;37(6):233-241. doi: 10.1080/07357907.2019.1624766. Epub 2019 Jul 11.

PMID:
31296072
14.

Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data.

Raab GT, Lin A, Hillyer GC, Keller D, O'Neil DS, Accordino MK, Buono DL, Hur C, Kiran RP, Wright JD, Hershman DL, Neugut AI.

Clin Colorectal Cancer. 2019 Sep;18(3):e294-e299. doi: 10.1016/j.clcc.2019.05.008. Epub 2019 Jun 8.

PMID:
31266707
15.

Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.

Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, St Clair CM, Ananth CV, Neugut AI, Hershman DL.

Obstet Gynecol. 2019 Jul;134(1):49-57. doi: 10.1097/AOG.0000000000003311.

PMID:
31188324
16.

Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer.

Syeda S, Chen L, Hou JY, Tergas AI, Khoury-Collado F, Melamed A, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Obstet Gynecol. 2019 Jul;134(1):17-29. doi: 10.1097/AOG.0000000000003287.

PMID:
31188310
17.

Regionalization of care for women with ovarian cancer.

Wright JD, Chen L, Buskwofie A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Hur C, Neugut AI, Hershman DL.

Gynecol Oncol. 2019 Aug;154(2):394-400. doi: 10.1016/j.ygyno.2019.05.025. Epub 2019 Jun 4.

PMID:
31171408
18.

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812).

Crew KD, Anderson GL, Hershman DL, Terry MB, Tehranifar P, Lew DL, Yee M, Brown EA, Kairouz SS, Kuwajerwala N, Bevers T, Doster JE, Zarwan C, Kruper L, Minasian LM, Ford L, Arun B, Neuhouser M, Goodman GE, Brown PH.

Cancer Prev Res (Phila). 2019 Jul;12(7):481-490. doi: 10.1158/1940-6207.CAPR-18-0444. Epub 2019 May 28.

PMID:
31138522
19.

Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer.

Wright JD, Huang Y, Melamed A, Tergas AI, St Clair CM, Hou JY, Khoury-Collado F, Ananth CV, Neugut AI, Hershman DL.

Obstet Gynecol. 2019 Jun;133(6):1109-1119. doi: 10.1097/AOG.0000000000003288.

PMID:
31135724
20.

Use of fertility preservation services in female reproductive-aged cancer patients.

Selter J, Huang Y, Grossman Becht LC, Palmerola KL, Williams SZ, Forman E, Ananth CV, Hur C, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2019 Oct;221(4):328.e1-328.e16. doi: 10.1016/j.ajog.2019.05.009. Epub 2019 May 18.

PMID:
31108063
21.

Neuronal Protection for Chemotherapy Neuropathy Prevention?

Loprinzi CL, Hershman DL, Staff N.

J Natl Cancer Inst. 2019 May 15. pii: djz088. doi: 10.1093/jnci/djz088. [Epub ahead of print] No abstract available.

PMID:
31093679
22.

Safety of same-day discharge for minimally invasive hysterectomy for endometrial cancer.

Praiss AM, Chen L, St Clair CM, Tergas AI, Khoury-Collado F, Hou JY, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2019 Sep;221(3):239.e1-239.e11. doi: 10.1016/j.ajog.2019.05.003. Epub 2019 May 10.

PMID:
31082381
23.

Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy.

Hwang JP, Huang D, Vierling JM, Suarez-Almazor ME, Shih YT, Chavez-MacGregor M, Duan Z, Giordano SH, Hershman DL, Fisch MJ, Cantor SB.

JCO Clin Cancer Inform. 2019 Mar;3:1-12. doi: 10.1200/CCI.18.00097.

24.

FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data.

Neugut AI, Lin A, Raab GT, Hillyer GC, Keller D, O'Neil DS, Accordino MK, Kiran RP, Wright J, Hershman DL.

Clin Colorectal Cancer. 2019 Jun;18(2):133-140. doi: 10.1016/j.clcc.2019.01.005. Epub 2019 Jan 31.

PMID:
30878317
25.

Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202.

Henry NL, Unger JM, Till C, Schott AF, Crew KD, Lew DL, Fisch MJ, Moinpour CM, Wade JL 3rd, Hershman DL.

Cancer. 2019 Jun 15;125(12):2123-2129. doi: 10.1002/cncr.32024. Epub 2019 Mar 12.

PMID:
30861098
26.

Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.

Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME.

J Natl Cancer Inst. 2019 Mar 1;111(3):245-255. doi: 10.1093/jnci/djy221.

27.

Endocrine-related quality of life in a randomized trial of exercise on aromatase inhibitor-induced arthralgias in breast cancer survivors.

Baglia ML, Lin IH, Cartmel B, Sanft T, Ligibel J, Hershman DL, Harrigan M, Ferrucci LM, Li FY, Irwin ML.

Cancer. 2019 Mar 6. doi: 10.1002/cncr.32051. [Epub ahead of print]

PMID:
30840336
28.

Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer.

Heilbroner SP, Xanthopoulos EP, Buono D, Huang Y, Carrier D, Shah A, Kim J, Corradetti M, Wright JD, Neugut AI, Hershman DL, Cheng SK.

Lung Cancer. 2019 Mar;129:8-15. doi: 10.1016/j.lungcan.2018.12.021. Epub 2018 Dec 24.

PMID:
30797496
29.

Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer.

Cham S, Chen L, St Clair CM, Hou JY, Tergas AI, Melamed A, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2019 Jun;220(6):571.e1-571.e8. doi: 10.1016/j.ajog.2019.02.019. Epub 2019 Feb 13.

PMID:
30771346
30.

Patterns of care and outcomes for women with uterine cancer and ovarian metastases.

Jones NL, Huang Y, Chatterjee S, Tergas AI, Burke WM, Hou JY, Deutsch I, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Int J Gynecol Cancer. 2019 Feb;29(2):365-376. doi: 10.1136/ijgc-2018-000047. Epub 2019 Jan 4.

PMID:
30718315
31.

Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma.

Leng S, Chen Y, Tsai WY, Bhutani D, Hillyer GC, Lim E, Accordino MK, Wright JD, Hershman DL, Lentzsch S, Neugut AI.

J Natl Compr Canc Netw. 2019 Jan;17(1):22-28. doi: 10.6004/jnccn.2018.7079.

PMID:
30659126
32.

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.

Ramsey SD, Unger JM, Baker LH, Little RF, Loomba R, Hwang JP, Chugh R, Konerman MA, Arnold K, Menter AR, Thomas E, Michels RM, Jorgensen CW, Burton GV, Bhadkamkar NA, Hershman DL.

JAMA Oncol. 2019 Apr 1;5(4):497-505. doi: 10.1001/jamaoncol.2018.6437. Erratum in: JAMA Oncol. 2019 Mar 7;:.

PMID:
30653226
33.

Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials.

Unger JM, Moseley A, Symington B, Chavez-MacGregor M, Ramsey SD, Hershman DL.

JAMA Netw Open. 2018 Aug 3;1(4):e181235. doi: 10.1001/jamanetworkopen.2018.1235.

34.

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.

Unger JM, Hershman DL, Fleury ME, Vaidya R.

JAMA Oncol. 2019 Mar 1;5(3):326-333. doi: 10.1001/jamaoncol.2018.5953. Erratum in: JAMA Oncol. 2019 Feb 14;:.

PMID:
30629092
35.

Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.

Hershman DL, Unger JM, Crew K.

JAMA. 2018 Dec 4;320(21):2270-2271. doi: 10.1001/jama.2018.16744. No abstract available.

PMID:
30512095
36.

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221).

Mongiovi JM, Zirpoli GR, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Thomas Budd G, Albain KS, Ambrosone CB, McCann SE.

Breast Cancer Res. 2018 Nov 28;20(1):146. doi: 10.1186/s13058-018-1077-9.

37.

Factors Associated With Follow-Up Care Among Women With Early-Stage Breast Cancer.

Quyyumi FF, Wright JD, Accordino MK, Buono D, Law CW, Hillyer GC, Neugut AI, Hershman DL.

J Oncol Pract. 2019 Jan;15(1):e1-e9. doi: 10.1200/JOP.18.00229. Epub 2018 Nov 8.

38.

Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients.

Greenlee H, Shi Z, Hibshoosh H, Giri DD, Ahmed A, Williams S, Falcone DJ, Winston LA, Zhou XK, Hudis CA, Hershman DL, Dannenberg AJ, Iyengar NM.

Cancer Prev Res (Phila). 2019 Jan;12(1):21-30. doi: 10.1158/1940-6207.CAPR-18-0207. Epub 2018 Nov 7.

39.

A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer.

Blanco C, Markowitz JC, Hellerstein DJ, Nezu AM, Wall M, Olfson M, Chen Y, Levenson J, Onishi M, Varona C, Okuda M, Hershman DL.

Breast Cancer Res Treat. 2019 Jan;173(2):353-364. doi: 10.1007/s10549-018-4994-5. Epub 2018 Oct 20.

PMID:
30343455
40.

Regional Market Competition and the Use of Immediate Breast Reconstruction After Mastectomy.

Wright JD, Chen L, Accordino M, Taback B, Ananth CV, Neugut AI, Hershman DL.

Ann Surg Oncol. 2019 Jan;26(1):62-70. doi: 10.1245/s10434-018-6825-7. Epub 2018 Oct 16.

PMID:
30327971
41.

Effect of Minimum-Volume Standards on Patient Outcomes and Surgical Practice Patterns for Hysterectomy.

Ruiz MP, Chen L, Hou JY, Tergas AI, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Obstet Gynecol. 2018 Nov;132(5):1229-1237. doi: 10.1097/AOG.0000000000002912.

PMID:
30303921
42.

Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008).

Greenlee H, Lew DL, Hershman DL, Newman VA, Hansen L, Hartman SJ, Korner J, Shi Z, Sardo Molmenti CL, Sayegh A, Fehrenbacher L, Lo S, Klemp J, Rinn K, Robertson JM, Unger J, Gralow J, Albain K, Krouse R, Fabian C.

Obesity (Silver Spring). 2018 Oct;26(10):1539-1549. doi: 10.1002/oby.22269. Epub 2018 Sep 11.

43.

National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer.

Seidman AD, Bordeleau L, Fehrenbacher L, Barlow WE, Perlmutter J, Rubinstein L, Wedam SB, Hershman DL, Hayes JF, Butler LP, Smith ML, Regan MM, Beaver JA, Amiri-Kordestani L, Rastogi P, Zujewski JA, Korde LA.

J Clin Oncol. 2018 Sep 13:JCO1800242. doi: 10.1200/JCO.18.00242. [Epub ahead of print]

PMID:
30212295
44.

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL 3rd, Fisch MJ, Henry NL, Hershman DL.

Breast Cancer Res Treat. 2018 Dec;172(3):603-610. doi: 10.1007/s10549-018-4946-0. Epub 2018 Aug 29.

PMID:
30159789
45.

Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers.

Nieto VL, Huang Y, Hou JY, Tergas AI, St Clair CM, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Am J Obstet Gynecol. 2018 Nov;219(5):463.e1-463.e12. doi: 10.1016/j.ajog.2018.07.028. Epub 2018 Aug 4.

PMID:
30086293
46.

Reply to T.P. Houston et al.

Hershman DL, Unger JM.

J Clin Oncol. 2018 Sep 20;36(27):2810-2811. doi: 10.1200/JCO.18.00285. Epub 2018 Jul 23. No abstract available.

PMID:
30036115
47.

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study.

Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD.

Cancer Med. 2018 Sep;7(9):4251-4260. doi: 10.1002/cam4.1657. Epub 2018 Jul 20.

48.

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.

Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD.

JAMA. 2018 Jul 10;320(2):167-176. doi: 10.1001/jama.2018.8907.

49.

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials.

Unger JM, Barlow WE, Tangen CM, Ramsey SD, Thompson IM Jr, Klein EA, LeBlanc M, Blanke CD, Goodman PJ, Minasian LM, Nghiem VT, Hershman DL.

Cancer Epidemiol. 2018 Aug;55:117-122. doi: 10.1016/j.canep.2018.06.005. Epub 2018 Jun 21.

50.

Changes in Surgical Volume and Outcomes Over Time for Women Undergoing Hysterectomy for Endometrial Cancer.

Wright JD, Ruiz MP, Chen L, Gabor LR, Tergas AI, St Clair CM, Hou JY, Ananth CV, Neugut AI, Hershman DL.

Obstet Gynecol. 2018 Jul;132(1):59-69. doi: 10.1097/AOG.0000000000002691.

Supplemental Content

Loading ...
Support Center